Ionis Prescription drugs, Inc. (NASDAQ:IONS) Wells Fargo twentieth Annual Healthcare Convention 2025 September 4, 2025 10:15 AM EDT
Firm Contributors
Brett Monia – Founder, CEO & Director
Convention Name Contributors
Yanan Zhu – Wells Fargo Securities, LLC, Analysis Division
Presentation
Yanan Zhu
Senior Fairness Analyst
Okay. Thanks, everybody, for being right here. I feel we will get began. My identify is Yanan Zhu. I am one of many biotech analysts right here at Wells Fargo. It’s our nice privilege to have the administration workforce of Ionis Prescription drugs right here for a fireplace chat session. And with me on stage is the CEO, Brett Monia.
Brett Monia
Founder, CEO & Director
Good morning, Yanan. Thanks.
Yanan Zhu
Senior Fairness Analyst
Thanks for being right here.
Brett Monia
Founder, CEO & Director
Sure, it is a pleasure.
Query-and-Reply Session
Yanan Zhu
Wells Fargo Securities, LLC, Analysis Division
Nice. It is thrilling time for Ionis. You may have 2 FDA approvals of wholly-owned merchandise within the final 12 months. Industrial launches are underway. Yet another indication simply reported very constructive knowledge after which 2 vital accomplice applications learn out in massive — for big market readouts subsequent 12 months. And we’re privileged to be the primary public look alternative after the very thrilling CORE and CORE2 knowledge earlier this week. May you share your perspective the place Ionis stands immediately and the place the story go from right here?
Brett Monia
Founder, CEO & Director
Certain. Joyful to, Yanan. I will be transient. However we have made — we have had super success during the last 2 or 3 years or so. And most lately, during the last 12 months or so, actually extraordinary progress throughout all elements of the enterprise. That features, after all, expertise advancing, however the pipeline has had so many successes, Part III readouts during the last 12 months or 2, drug approvals, as you talked about 2 medicine have been accepted during the last 9 months that we independently personal ourselves. There’s
